These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31882295)

  • 1. Synthesis and biological evaluation of 4-arylcoumarins as potential anti-Alzheimer's disease agents.
    Yun Y; Yang J; Miao Y; Wang X; Sun J
    Bioorg Med Chem Lett; 2020 Feb; 30(4):126900. PubMed ID: 31882295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of 3-arylcoumarins as potential anti-Alzheimer's disease agents.
    Yang J; Zhang P; Hu Y; Liu T; Sun J; Wang X
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):651-656. PubMed ID: 30746966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional 5,6-dimethoxybenzo[d]isothiazol-3(2H)-one-N-alkylbenzylamine derivatives with acetylcholinesterase, monoamine oxidases and β-amyloid aggregation inhibitory activities as potential agents against Alzheimer's disease.
    Xu R; Xiao G; Li Y; Liu H; Song Q; Zhang X; Yang Z; Zheng Y; Tan Z; Deng Y
    Bioorg Med Chem; 2018 May; 26(8):1885-1895. PubMed ID: 29500132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, pharmacological study and docking calculations of new benzo[f]coumarin derivatives as dual inhibitors of enzymatic systems involved in neurodegenerative diseases.
    Matos MJ; Janeiro P; González Franco RM; Vilar S; Tatonetti NP; Santana L; Uriarte E; Borges F; Fontenla JA; Viña D
    Future Med Chem; 2014 Mar; 6(4):371-83. PubMed ID: 24635520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.
    Samadi A; de los Ríos C; Bolea I; Chioua M; Iriepa I; Moraleda I; Bartolini M; Andrisano V; Gálvez E; Valderas C; Unzeta M; Marco-Contelles J
    Eur J Med Chem; 2012 Jun; 52():251-62. PubMed ID: 22503231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease.
    Sterling J; Herzig Y; Goren T; Finkelstein N; Lerner D; Goldenberg W; Miskolczi I; Molnar S; Rantal F; Tamas T; Toth G; Zagyva A; Zekany A; Finberg J; Lavian G; Gross A; Friedman R; Razin M; Huang W; Krais B; Chorev M; Youdim MB; Weinstock M
    J Med Chem; 2002 Nov; 45(24):5260-79. PubMed ID: 12431053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
    Bolea I; Juárez-Jiménez J; de Los Ríos C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A
    J Med Chem; 2011 Dec; 54(24):8251-70. PubMed ID: 22023459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental and Computational Evaluation of Piperonylic Acid Derived Hydrazones Bearing Isatin Moieties as Dual Inhibitors of Cholinesterases and Monoamine Oxidases.
    Vishnu MS; Pavankumar V; Kumar S; Raja AS
    ChemMedChem; 2019 Jul; 14(14):1359-1376. PubMed ID: 31177620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids.
    Bautista-Aguilera OM; Esteban G; Chioua M; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Soriano E; Samadi A; Unzeta M; Marco-Contelles J
    Drug Des Devel Ther; 2014; 8():1893-910. PubMed ID: 25378907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 4-substituted benzyl-2-triazole-linked-tryptamine-paeonol derivatives and evaluation of their selective inhibitions against butyrylcholinesterase and monoamine oxidase-B.
    Oh JM; Kang Y; Hwang JH; Park JH; Shin WH; Mun SK; Lee JU; Yee ST; Kim H
    Int J Biol Macromol; 2022 Sep; 217():910-921. PubMed ID: 35908673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphenylalkoxyamine Derivatives-Histamine H
    Łażewska D; Zaręba P; Godyń J; Doroz-Płonka A; Frank A; Reiner-Link D; Bajda M; Stary D; Mogilski S; Olejarz-Maciej A; Kaleta M; Stark H; Malawska B; Kieć-Kononowicz K
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34208297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.
    Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V
    ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 7-Amidocoumarins as Multitarget Agents against Neurodegenerative Diseases: Substitution Pattern Modulation.
    Rodríguez-Enríquez F; Viña D; Uriarte E; Laguna R; Matos MJ
    ChemMedChem; 2021 Jan; 16(1):179-186. PubMed ID: 32700464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship studies of benzyl-, phenethyl-, and pyridyl-substituted tetrahydroacridin-9-amines as multitargeting agents to treat Alzheimer's disease.
    Osman W; Mohamed T; Sit VM; Vasefi MS; Beazely MA; Rao PP
    Chem Biol Drug Des; 2016 Nov; 88(5):710-723. PubMed ID: 27282589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease.
    Li F; Wang ZM; Wu JJ; Wang J; Xie SS; Lan JS; Xu W; Kong LY; Wang XB
    J Enzyme Inhib Med Chem; 2016; 31(sup3):41-53. PubMed ID: 27384289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease.
    Bai P; Wang K; Zhang P; Shi J; Cheng X; Zhang Q; Zheng C; Cheng Y; Yang J; Lu X; Sang Z
    Eur J Med Chem; 2019 Dec; 183():111737. PubMed ID: 31581002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent and selective MAO-B inhibitory activity: amino- versus nitro-3-arylcoumarin derivatives.
    Matos MJ; Rodríguez-Enríquez F; Vilar S; Santana L; Uriarte E; Hripcsak G; Estrada M; Rodríguez-Franco MI; Viña D
    Bioorg Med Chem Lett; 2015 Feb; 25(3):642-8. PubMed ID: 25532905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis and in vitro Evaluation of Indolotacrine Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease.
    Benek O; Soukup O; Pasdiorova M; Hroch L; Sepsova V; Jost P; Hrabinova M; Jun D; Kuca K; Zala D; Ramsay RR; Marco-Contelles J; Musilek K
    ChemMedChem; 2016 Jun; 11(12):1264-9. PubMed ID: 26427608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Oxoquinoline-based-thiosemicarbazones as multitargeting neurotherapeutics against Alzheimer's disease: In vitro and in silico studies of MAO and ChE inhibitors.
    Basri R; Fatima S; Jalil S; Imran A; Fatima N; Syed A; Bahkali AH; Iqbal J; Shafiq Z
    Arch Pharm (Weinheim); 2023 Nov; 356(11):e2300430. PubMed ID: 37718357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipropargyl substituted diphenylpyrimidines as dual inhibitors of monoamine oxidase and acetylcholinesterase.
    Kumar B; Kumar V; Prashar V; Saini S; Dwivedi AR; Bajaj B; Mehta D; Parkash J; Kumar V
    Eur J Med Chem; 2019 Sep; 177():221-234. PubMed ID: 31151057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.